![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Brueckner, Isabel; Welter-Luedeke, Jessica; Gutjahr-Ruhland, Claudia; Graw, Matthias und Paul, Liane 
ORCID: https://orcid.org/0000-0003-1923-0351
(18. April 2025):
Toxicological detection of the new psychoactive substances MDPHP and MDPHpP in human urine samples by elucidation of their urinary metabolites using gas chromatography–mass spectrometry.
In: Journal of Analytical Toxicology, Bd. 49, Nr. 5: S. 299-314
ORCID: https://orcid.org/0000-0003-1923-0351
(18. April 2025):
Toxicological detection of the new psychoactive substances MDPHP and MDPHpP in human urine samples by elucidation of their urinary metabolites using gas chromatography–mass spectrometry.
In: Journal of Analytical Toxicology, Bd. 49, Nr. 5: S. 299-314
Brueckner, Isabel; Welter-Luedeke, Jessica; Zangl, Anna; Graw, Matthias und Paul, Liane ORCID: https://orcid.org/0000-0003-1923-0351
(2024):
α-Pyrrolidinohexanophenone (α-PHP) vs. α-pyrrolidinoisohexanophenone (α-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.
In: Journal of Analytical Toxicology, Bd. 48, Nr. 5: S. 299-313
ORCID: https://orcid.org/0000-0003-1923-0351
(2024):
α-Pyrrolidinohexanophenone (α-PHP) vs. α-pyrrolidinoisohexanophenone (α-PiHP): A toxicological investigation about plasma concentrations and behavior in forensic routine cases.
In: Journal of Analytical Toxicology, Bd. 48, Nr. 5: S. 299-313
Paul, Liane D.; Welter-Luedeke, Jessica; Penzel, Saskia; Zangl, Anna und Graw, Matthias
(2021):
Alpha-Pyrrolidinopentiothiophenone (alpha-PVT): A forensic case study including plasma concentrations.
In: Forensic Science International, Bd. 321, 110721
Welter-Luedeke, Jessica und Maurer, Hans H.
(2016):
New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems.
In: Therapeutic Drug Monitoring, Bd. 38, Nr. 1: S. 4-11